SNF COAGULANTS : revenue, balance sheet and financial ratios

SNF COAGULANTS is a French company founded 9 years ago, specialized in the sector Fabrication d'autres produits chimiques inorganiques de base n.c.a.. Based in SAINT-AVOLD (57500), this company of category ETI shows in 2024 a revenue of 8.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SNF COAGULANTS (SIREN 821155124)
Indicator 2024 2023 2020 2019 2018 2017
Revenue 8 333 209 € 8 372 517 € 4 184 154 € 5 700 778 € 2 068 083 € N/C
Net income 76 957 € 287 131 € -921 350 € 30 181 € 66 529 € 11 479 €
EBITDA 4 812 431 € 5 316 824 € 1 934 500 € 3 834 266 € 1 101 553 € 20 769 €
Net margin 0.9% 3.4% -22.0% 0.5% 3.2% N/C

Revenue and income statement

In 2024, SNF COAGULANTS achieves revenue of 8.3 M€. Over the period 2018-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +26.1%. Slight decline of -0% vs 2023. After deducting consumption (60 k€), gross margin stands at 8.3 M€, i.e. a rate of 99%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 4.8 M€, representing 57.8% of revenue. Warning negative scissor effect: despite revenue change (-0%), EBITDA varies by -9%, reducing margin by 5.8 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 77 k€, i.e. 0.9% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

8 333 209 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

8 273 115 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

4 812 431 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 292 071 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

76 957 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

56.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 192%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.0 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 47.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

192.042%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

32.368%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

47.876%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

5.042

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

71.5%

Solvency indicators evolution
SNF COAGULANTS

Sector positioning

Debt ratio
192.04 2024
2020
2023
2024
Q1: 0.0
Med: 2.78
Q3: 24.44
Watch -6 pts over 3 years

In 2024, the debt ratio of SNF COAGULANTS (192.04) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
32.37% 2024
2020
2023
2024
Q1: 37.18%
Med: 52.32%
Q3: 73.27%
Watch

In 2024, the financial autonomy of SNF COAGULANTS (32.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
5.04 years 2024
2020
2023
2024
Q1: 0.0 years
Med: 0.05 years
Q3: 1.18 years
Watch +18 pts over 3 years

In 2024, the repayment capacity of SNF COAGULANTS (5.04) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 27.79. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 15.6x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

27.787

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

15.619

Liquidity indicators evolution
SNF COAGULANTS

Sector positioning

Liquidity ratio
27.79 2024
2020
2023
2024
Q1: 110.5
Med: 196.93
Q3: 369.67
Watch

In 2024, the liquidity ratio of SNF COAGULANTS (27.79) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
15.62x 2024
2020
2023
2024
Q1: 0.0x
Med: 3.18x
Q3: 8.53x
Excellent

In 2024, the interest coverage of SNF COAGULANTS (15.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 152 days. Excellent situation: suppliers finance 151 days of the operating cycle (retail model). WCR is negative (-294 days): operations structurally generate cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-6 800 399 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

1 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

152 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-294 j

WCR and payment terms evolution
SNF COAGULANTS

Positioning of SNF COAGULANTS in its sector

Comparison with sector Fabrication d'autres produits chimiques inorganiques de base n.c.a.

Valuation estimate

Based on 74 transactions of similar company sales (all years), the value of SNF COAGULANTS is estimated at 1 786 832 € (range 638 557€ - 4 158 126€). With an EBITDA of 4 812 431€, the sector multiple of 0.6x is applied. The price/revenue ratio is 0.11x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
74 tx
638k€ 1786k€ 4158k€
1 786 832 € Range: 638 557€ - 4 158 126€
Section all-time Aggregated at NAF section level

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
4 812 431 € × 0.6x
Estimation 3 007 893 €
911 254€ - 6 936 296€
Revenue Multiple 30%
8 333 209 € × 0.11x
Estimation 915 355 €
597 347€ - 2 082 570€
Net Income Multiple 20%
76 957 € × 0.5x
Estimation 41 398 €
18 631€ - 326 037€
How is this estimate calculated?

This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication d'autres produits chimiques inorganiques de base n.c.a.)

Compare SNF COAGULANTS with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication d'autres produits chimiques inorganiques de base n.c.a.

Frequently asked questions about SNF COAGULANTS

What is the revenue of SNF COAGULANTS ?

The revenue of SNF COAGULANTS in 2024 is 8.3 M€.

Is SNF COAGULANTS profitable?

Yes, SNF COAGULANTS generated a net profit of 77 k€ in 2024.

Where is the headquarters of SNF COAGULANTS ?

The headquarters of SNF COAGULANTS is located in SAINT-AVOLD (57500), in the department Moselle.

Where to find the tax return of SNF COAGULANTS ?

The tax return of SNF COAGULANTS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SNF COAGULANTS operate?

SNF COAGULANTS operates in the sector Fabrication d'autres produits chimiques inorganiques de base n.c.a. (NAF code 20.13B). See the 'Sector positioning' section above to compare the company with its competitors.